US FDA Consultants for Medical Devices, Drugs, Food and Cosmetics
US FDA consultants help manufacturers get products onto the US market and keep them there. I3CGLOBAL’s FDA consultants prepare 510(k) submissions, complete FDA registration and listing, act as your US agent, support FDA inspections, write FDA 483 responses and run pre- and post-inspection audits and gap assessments for medical device, IVD, drug, dietary supplement, food and cosmetic companies worldwide.
At a glance
The basics
What Do US FDA Consultants Do?
US FDA consultants are regulatory specialists who plan, prepare and defend the work a manufacturer needs to sell an FDA-regulated product in the United States. That covers choosing the right regulatory pathway, writing premarket submissions, registering facilities and listing products, building a quality system that meets FDA rules, and preparing the site and the team for an FDA inspection.
Good FDA consulting is not a one-off document. It runs through the whole product life cycle, from the first classification decision to the inspection that follows years of US sales. The questions change at each stage:
- Before market entry: how is the product classified, which submission applies, and which FDA labeling requirements must be met?
- At market entry: is the 510(k) submission complete, is the establishment registered, and is a US agent named?
- On the market: does the quality system hold up during an inspection, and can the company answer an FDA Form 483 quickly and credibly?
Our FDA consultants have done this work for manufacturers in more than 40 countries. Many are first-time exporters to the United States who need a partner that knows both the regulations and the realities of a factory floor. If you are new to the US route, start with our overview of FDA approval and US FDA registration.
What we do
FDA Consulting Services From Our US FDA Consultants
You can hand our team the complete project or use us for a single task. Every FDA consulting service below is delivered by consultants who specialise in that area, with a fixed scope, fee and timeline agreed before work starts.
510(k) and De Novo
Predicate selection, testing plan, eSTAR file and FDA review support. See 510k consultants.
Registration and listing
Establishment registration, device and drug listing, food and cosmetic facility registration and annual renewals.
US FDA agent
The US agent that foreign establishments must name, available for devices, drugs, food and cosmetics.
QMSR and GMP
Quality systems for 21 CFR 820, 21 CFR 211 and 21 CFR 111, built to pass an FDA audit.
FDA inspection support
Readiness planning, front-room and back-room support and investigator interview coaching.
Pre- and post-inspection audits
Mock inspections before FDA arrives and CAPA effectiveness audits after it leaves.
GAP assessments
QMS, labeling, technical file and data integrity gap assessments against current FDA rules.
FDA 483 response
Root cause analysis, CAPA plans and a written response delivered within 15 business days.
Warning letters and DMFs
Warning letter remediation through to close-out, and Drug Master File preparation.
Premarket submissions
FDA Consulting for 510k Clearance
Most Class II medical devices, and some Class I devices, need 510(k) clearance before they can be sold in the United States. The 510(k) must show the device is substantially equivalent to a legally marketed predicate device. Our FDA consulting for 510k covers the full route, from the first classification check to the clearance letter.
- 1. Classification and pathwayWe confirm the product code and regulation number using our FDA medical device classification method, and decide between 510(k), De Novo and PMA.
- 2. Predicate and test planWe select the predicate device and plan biocompatibility, electrical safety, software and performance testing that FDA guidance expects.
- 3. Pre-SubmissionWhere testing is uncertain, we prepare a Q-Sub so FDA comments on your plan before you pay for studies.
- 4. eSTAR and FDA reviewWe build the eSTAR file, file it through the CDRH Portal and answer additional information requests until FDA decides.
FDA fee, FY 2027: the standard 510(k) review fee is USD 28,653, or USD 7,163 for a qualified small business, from 1 October 2026 to 30 September 2027 (Federal Register). See our FDA 510k fees page or the 510k cost calculator.
Market access
FDA Consulting for Registration and Listing of Medical Devices
Every establishment that makes, repackages, relabels or imports a medical device for the US market must register with FDA and list its devices under 21 CFR 807. Registration is renewed every year between 1 October and 31 December, and the annual establishment registration fee must be paid before FDA accepts it. A foreign establishment must also name a US agent.
Our FDA consultants manage the full process in the FDA Unified Registration and Listing System (FURLS): paying the user fee, registering the establishment, listing each device under the right product code, adding 510(k) numbers and keeping the record current when products or addresses change.
| Product | Rule | Renewal | What we handle |
|---|---|---|---|
| Medical devices and IVDs | 21 CFR 807 | Every year, 1 Oct–31 Dec | Fee payment, registration, device listing and US agent. FY 2027 fee: USD 13,785 |
| Drugs and APIs | 21 CFR 207 | Every year, 1 Oct–31 Dec | SPL registration, drug listing, labeler code and US agent |
| Food and supplements | 21 CFR 1, Subpart H | Every 2 years, 1 Oct–31 Dec of even years | Food facility registration, renewal and US agent |
| Cosmetics | MoCRA (FD&C Act section 607) | Facility every 2 years; listings updated yearly | Facility registration, product listing and responsible person |
Details by product: FDA medical device registration, device registration fee, drug establishment registration, food facility registration and cosmetic registration. Registration is not FDA approval: FDA does not issue certificates for it, so beware of anyone selling an “FDA certificate”. Read more on US FDA certificates.
Inspections
FDA Inspection Support From Experienced FDA Consultants
An FDA investigator inspects what is actually in place, not what is planned. One missing record or one unclear answer can become an observation on Form FDA 483. For foreign sites, repeated or serious findings can lead to an import alert that stops shipments at the US border. FDA inspection support from our consultants prepares the site, the documents and the people.
Since 2 February 2026, medical device inspections follow the Quality Management System Regulation (QMSR), which incorporates ISO 13485:2016 by reference. FDA replaced the QSIT inspection technique with a new risk-based approach under Compliance Program 7382.850. Our QMSR consultants prepare device makers for this new style of inspection.
Types of FDA inspection we prepare you for
Pre-approval inspections
Before approving a PMA, NDA or ANDA, FDA checks that the site can make the product as described. 510(k) devices are usually not inspected before clearance, but the site can be inspected at any time after.
Routine surveillance
Scheduled, risk-based inspections of registered sites. Foreign sites often receive notice weeks ahead, which is the time to run a mock audit.
Compliance follow-up
After a 483 or warning letter, FDA returns to check that corrective actions are in place and working.
For-cause inspections
Triggered by complaints, adverse event reports, recalls or other information, often with little warning.
During the inspection we can support you on site or remotely: running the back room, checking each document before it goes to the investigator, coaching subject matter experts and keeping a daily log of requests and verbal observations. More detail is in our USFDA inspection guide.
Audits
FDA Pre-Inspection and Post-Inspection Audits and GAP Assessments
A GAP assessment compares what you do today with what FDA requires and gives a prioritised list of fixes. Our FDA consultants run it as an FDA investigator would: tracing records, interviewing staff and following a product from complaint to CAPA. The result is a written report with a risk rating and a realistic plan to close each gap.
- Mock FDA inspection over 2 to 5 days
- QMSR, GMP and ISO 13485 gap assessment
- Complaint, CAPA, MDR and recall file review
- Design history, risk file and labeling checks
- Data integrity and supplier control review
- Front-room and back-room rehearsal
- Review of each 483 observation and verbal comment
- Root cause and systemic impact analysis
- CAPA implementation and effectiveness checks
- Progress reports to FDA after the first response
- Readiness for a compliance follow-up inspection
- Warning letter close-out support
We also run focused gap assessments for FDA labeling, UDI, cybersecurity and the transition from ISO 13485 certification to the QMSR. If you hold MDSAP certification, FDA can accept an MDSAP audit report in place of a routine inspection, and we can prepare you for that too.
After the inspection
FDA 483 Response Preparation and Warning Letter Support
Form FDA 483, Inspectional Observations, is handed to company management at the end of an inspection when the investigator has seen conditions that may break FDA rules. It is not a final agency decision, but it is the moment that decides whether a warning letter follows. FDA’s 2009 Federal Register notice says it will consider a response received within 15 business days before deciding on further action. A late or weak response is usually ignored.
- 1. Read the observationsDay 1: we review the 483, the investigator’s notes and the documents collected.
- 2. Find the root causeWe look beyond the example cited to find how far the problem reaches across products and systems.
- 3. Build the CAPA planCorrections, corrective actions and preventive actions, each with an owner, a date and evidence.
- 4. Write the responseA clear, numbered reply that commits only to what you can deliver, with supporting records attached.
- 5. Submit within 15 business daysWe send the response to the FDA office named on the 483 and keep proof of delivery.
- 6. Follow upMonthly or quarterly updates until all actions are complete and verified.
Warning letters: if FDA issues a warning letter, you are normally asked to respond within 15 working days. Our consultants support warning letter remediation through to close-out, including third-party audits that FDA may expect before it lifts an import alert.
Scope
Products Our FDA Consultants Cover
FDA rules differ by product type. Our FDA consultants work within each set of rules, and many clients use us for more than one product, for example a device maker that also sells a cosmetic or an OTC drug.
| Product type | Main FDA rules | Typical FDA consulting work |
|---|---|---|
| Medical devices and IVDs | 21 CFR 807, 820, 801, 803 | Classification, 510(k), De Novo, QMSR, UDI, registration, inspections |
| Drugs, APIs and OTC | 21 CFR 207, 210, 211 | GMP, drug registration, DMF, pre-approval inspection readiness |
| Dietary supplements | 21 CFR 111 | GMP systems, labeling review, facility registration |
| Food and beverages | 21 CFR 1 Subpart H, 117 | Facility registration, FSMA preventive controls, labeling |
| Cosmetics | MoCRA | Facility registration, product listing, safety substantiation |
For pharmaceutical sites we also support GMP certification and stability studies. Device makers selling in Europe as well can combine FDA work with our 510k and CE marking comparison and ISO 13485 consultants.
Why I3CGLOBAL
Why Manufacturers Choose I3CGLOBAL as Their US FDA Consultants
Choosing FDA consultants is a decision about risk. These are the reasons manufacturers in India, Europe, the UK, South Korea, Vietnam, Malaysia and the Middle East keep working with us.
Specialists, not generalists
Separate teams for devices, IVDs, software, drugs, food and cosmetics, each focused on its own FDA rules.
Whole life cycle
The same team can take you from classification to clearance, registration and your first inspection.
Fast when it matters
A 483 response plan within days, so you can meet the 15-business-day window with evidence, not promises.
Global and local
Offices in the USA, UK, Germany, Portugal, India, Malaysia and Vietnam, associate partners in South Korea and Thailand, and work across time zones for international factories.
Fixed fee and timeline
Scope, price and dates agreed in writing before work starts. Use our registration cost calculator for a first estimate.
Proven track record
800+ manufacturers supported. Read our medical device case studies, including 13 FDA 510(k) projects.
- Plain answers on what FDA requires, with the regulation behind each one
- No unnecessary testing or paperwork added to the scope
- Direct access to the consultant doing the work
Compare your options
FDA Consultants vs In-House Team vs US Agent Only
Manufacturers selling in the United States usually choose one of three models. An in-house regulatory team suits companies with a steady pipeline of US products. A US agent alone covers only FDA communication for a foreign site. US FDA consultants add specialist submission, inspection and FDA 483 experience when you need it, without permanent headcount.
| Factor | US FDA consultants | In-house regulatory team | US agent only |
|---|---|---|---|
| Best for | First US entry, peak workload, inspections and urgent 483s | Large portfolios with continuous US submissions | Foreign sites that already have regulatory support |
| What it covers | Strategy, 510(k) and eCTD files, registration, QMSR and GMP, audits, 483 and warning letter responses | Whatever the team has the skills and time for | FDA communication and help scheduling inspections (21 CFR 807.40); no submissions or remediation |
| Inspection and 483 experience | Many inspections across companies and product types | Limited to your own sites’ history | Not part of the role |
| Time to start | Days, under an agreed scope | Months to hire and train | Days |
| Cost model | Fixed fee per project | Salaries, training and tools year round | Annual service fee |
| Main risk | Needs clear scope and access to your records | Gaps when key people leave or workload peaks | Compliance gaps stay with the manufacturer |
Many I3CGLOBAL clients combine the models: an in-house regulatory lead for day-to-day work, our FDA consultants for submissions, mock inspections and 483 responses, and I3CGLOBAL as their US FDA agent.
Work with I3CGLOBAL
Talk to Our FDA Consultants Today
Tell us your product, your target date and where you are today. Our FDA consultants will reply with a clear plan and a fixed-fee proposal, whether you need a 510(k), FDA registration, inspection support or an urgent 483 response.
- 510(k), De Novo and registration
- Inspection support and mock audits
- FDA 483 and warning letter responses
Get your proposal
Share your product and FDA question, and we will reply within one business day.
FAQs
US FDA Consultants: Frequently Asked Questions
What do US FDA consultants do?
US FDA consultants help manufacturers meet FDA rules to sell in the United States. They choose the regulatory pathway, prepare submissions such as a 510(k), register facilities and list products, build quality systems, prepare sites for FDA inspections and write responses to FDA Form 483 observations and warning letters.
Why hire FDA consultants instead of doing it in-house?
Experienced FDA consultants know what FDA reviewers and investigators expect, so files and responses are right the first time. This avoids holds, repeat testing and enforcement risk, and frees your team to run the business. Many companies use consultants for specific tasks and keep routine work in-house.
How much do FDA consulting services cost?
Fees depend on the product and the scope. Registration and listing is a small fixed fee plus the FDA user fee, while a 510(k) or inspection remediation project costs more. I3CGLOBAL agrees a fixed fee and timeline in writing before work starts.
Do you provide FDA consulting for 510k submissions?
Yes. Our FDA consulting for 510k covers classification, predicate selection, test planning, Pre-Submission meetings, eSTAR preparation and responses to FDA additional information requests until clearance.
Do you handle FDA registration and listing for medical devices?
Yes. We pay the annual establishment registration fee, register the establishment, list each device in FURLS, add 510(k) numbers and renew the registration every year between 1 October and 31 December.
Do foreign manufacturers need a US agent?
Yes. Foreign device, drug, food and cosmetic establishments must name a US agent when they register with FDA. I3CGLOBAL can act as your US FDA agent.
How long do I have to respond to an FDA Form 483?
FDA will consider a written response received within 15 business days of the end of the inspection before it decides whether to issue a warning letter. A response sent later is usually not considered in that decision.
What is the difference between a Form 483 and a warning letter?
A Form 483 lists an investigator's observations at the end of an inspection and is not a final FDA decision. A warning letter is formal notice from FDA that it considers the company in significant violation, and it is published on the FDA website.
Do you conduct mock FDA inspections and GAP assessments?
Yes. We run pre-inspection mock audits and GAP assessments against QMSR, GMP and labeling rules, and post-inspection audits that check CAPA effectiveness before FDA returns.
How has the QMSR changed FDA inspections of device makers?
Since 2 February 2026, FDA inspects medical device makers against the Quality Management System Regulation, which incorporates ISO 13485:2016. The old QSIT technique was replaced by a risk-based approach under Compliance Program 7382.850.
Do your FDA consultants support drugs, food and cosmetics?
Yes. Besides medical devices and IVDs, we support drug and API establishment registration and GMP, dietary supplement GMP, food facility registration and cosmetic facility registration and product listing under MoCRA.
